Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis

Alzheimer’s disease (AD) is a neurodegenerative disease that causes memory loss, cognitive decline, and eventually dementia. The etiology of AD and its pathological mechanisms remain unclear due to its complex pathobiology. At the same time, the number of patients with AD is increasing worldwide. Ho...

Descripción completa

Detalles Bibliográficos
Autor principal: Tashima, Toshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876001/
https://www.ncbi.nlm.nih.gov/pubmed/35214143
http://dx.doi.org/10.3390/pharmaceutics14020411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876001/
https://www.ncbi.nlm.nih.gov/pubmed/35214143
http://dx.doi.org/10.3390/pharmaceutics14020411

Ejemplares similares